Forte Biosciences (FBRX) Other Operating Expenses (2016 - 2026)
Forte Biosciences (FBRX) posted quarterly Other Operating Expenses of $150000.0 for Q1 2026, little changed year-over-year from $150000.0 in Q1 2025, and little changed quarter-over-quarter from $150000.0 in Q4 2025.
Forte Biosciences (FBRX) Other Operating Expenses (2016 - 2026) Analysis & Trends
Forte Biosciences (FBRX) has reported Other Operating Expenses for 8 consecutive years, with $150000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Operating Expenses changed 0.0% year-over-year to $150000.0; the TTM figure through Mar 2026 stood at $600000.0 (changed 0.0% YoY), while the FY2025 annual figure was $600000.0, up 25.26% from the prior year.
- Other Operating Expenses steadied at $150000.0 in Q1 2026 per FBRX's latest filing, from $150000.0 in the prior quarter.
- Across five years, Other Operating Expenses topped out at $150000.0 in Q2 2024 and bottomed at $29000.0 in Q1 2024.
- Historically, Other Operating Expenses has averaged $136555.6 across 3 years, with a median of $150000.0 in 2024.
- On a YoY basis, Other Operating Expenses climbed as much as 417.24% in 2025 and fell as far as 0.0% in 2025.
- Forte Biosciences' Other Operating Expenses stood at $150000.0 in 2024, then changed by 0.0% to $150000.0 in 2025, then changed by 0.0% to $150000.0 in 2026.
- Business Quant data shows FBRX's Other Operating Expenses at $150000.0 in Q1 2026, $150000.0 in Q4 2025, and $150000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Forte Biosciences | 1.63 Bn | 1.28 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 150,000.00 |
| Mar 31, 2026 | 150,000.00 |
| Dec 31, 2025 | 150,000.00 |
| Sep 30, 2025 | 150,000.00 |
| Jun 30, 2025 | 150,000.00 |
| Mar 31, 2025 | 150,000.00 |
| Dec 31, 2024 | 150,000.00 |
| Sep 30, 2024 | 150,000.00 |
| Jun 30, 2024 | 150,000.00 |
| Mar 31, 2024 | 29,000.00 |
| Jun 30, 2020 | 32.06 Mn |
| Mar 31, 2020 | -885,000.00 |
| Dec 31, 2019 | 9.15 Mn |
| Dec 31, 2018 | -1,000.00 |
| Dec 31, 2017 | -1,000.00 |
| Dec 31, 2016 | 1,000.00 |